Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05326633 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 78
- Enrollment target
NCT05326633: Clinical Trial Early Phase 1 study, sponsored by University of Maryland, Baltimore.
NCT05326633 is a Early Phase 1 study that has not yet begun recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 78 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05326633, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Maryland, Baltimore.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 78 participants
- Enrollment target
Study Summary
Older ICU survivors with ICU acquired weakness (ICUAW) are malnourished, sarcopenic, and functionally debilitated as a consequence of the high burden of comorbidities common in the elderly. To address the sequalae of critical illnesses, the investigators will perform a trial incorporating an intervention that combines mobility-based physical rehabilitation (MRP), high protein supplementation (HPRO), and neuromuscular electric stimulation (NMES). The investigators will then assess both clinical and functional outcomes and determine the relationship of disability with systemic inflammation.
Primary Outcome
Muscle mass will be measured by lower extremity muscle CT scans to calculate muscle volume and cross sectional area.
Interventions
- COMBINATION_PRODUCT MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2027-03-01 |
| Est. Completion | 2029-10-30 |
| Phase | Early Phase 1 |
What is known before NCT05326633 opens enrollment
NCT05326633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 1 intervention - of which MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES) is the first listed.
NCT05326633 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05326633 about?
NCT05326633 is a clinical study titled "Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors". Older ICU survivors with ICU acquired weakness (ICUAW) are malnourished, sarcopenic, and functionally debilitated as a consequence of the high burden of comorbidities common in the elderly. To address the sequalae of critical illnesses, the investigators will perform a trial incorporating an interve...
What is the current status of trial NCT05326633?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 78 participants. The study started on 2027-03-01. Estimated completion is 2029-10-30.
What interventions are being tested in trial NCT05326633?
The interventions under investigation include: MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05326633?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05326633's enrollment target sits among peer trials
78 300th of 2000 higher than 1,699 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI